Published: 08 February 2021
The NIHR Clinical Research Network (CRN) has appointed Divya Chadha Manek as its new Director of Business Development and Marketing, following an open competitive recruitment process. She will take up the position in April 2021.
As Director of Business Development and Marketing, Divya will lead the NIHR Clinical Research Network’s directorate responsible for increasing investment into UK health and social care research from both non-commercial and commercial research sponsors, including the global life sciences industry.
Divya has worked as the NIHR CRN’s Head of Commercial Business Development since 2015 - over which time she has led the implementation and delivery of the CRN’s five year Business Development and Marketing strategy.
More recently, Divya has spent the last year on secondment to the UK Vaccines Taskforce as the clinical trials lead responsible for overseeing the UK COVID-19 vaccine clinical trials portfolio. In this key role, Divya has been instrumental in supporting companies to bring vaccine trials to the UK, generating the data required for marketing authorisation. She also played a key role in the development of the Vaccine Research Registry.
Dr William van’t Hoff, Chief Executive of the NIHR Clinical Research Network said:
“I am delighted to announce the appointment of Divya Chadha Manek as our new Business Development and Marketing Director. Divya brings a wealth of first-hand experience within commercial business development, alongside an exceptional track record of increasing investment in UK commercial clinical research supported by the NIHR and the NHS.”
On her appointment, Divya said: “I am hugely passionate about the work that the NIHR Clinical Research Network does to improve the health and wealth of the nation through research, and feel greatly privileged in having the opportunity to contribute to the vision of the organisation.
“Even in the midst of a pandemic and post-Brexit environment, I am very excited to help shape the future direction of NIHR Clinical Research Network. I hope to be able to use my experience and extensive relationships with key stakeholders right across the sector, both within the UK and internationally, to help ensure the UK continues to be seen as a destination of choice to deliver clinical research.”